Advagen Pharma Europe OÜ
Advagen Pharma Europe OÜ is Osaühing. The main activity is Ravimpreparaatide tootmine (21201). The company is located in Harju maakond. Founded 15/05/2023. Share capital is 0 €. 2023 figures: revenue 354,702 €, profit 6,715 €, employees 0. Taxes for I quarter of 2025 were 58 €. No tax debt.
Key figures
- Year
- 2023
- Revenue
- 354,702 €
- Net profit
- 6,715 €
Signals
Financials
2023: revenue 354,702 €, net profit 6,715 €.